Ultragenyx to Present at the JMP Securities Healthcare Conference

By GlobeNewswire,  June 18, 2014, 09:00:00 AM EDT


Novato, CA, June 18, 2014 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today announced that Emil D. Kakkis, M.D., Ph.D., the company's Chief Executive Officer, will be presenting at the JMP Securities Healthcare Conference on June 25, 2014 at 2:30pm ET at the Westin New York Grand Central.

The live and archived webcast of the company presentation will be accessible from the company's website at http://ir.ultragenyx.com/events.cfm. The replay of the webcast will be available approximately one hour after the conclusion of the live presentation and will be available for 180 days.

About Ultragenyx

Ultragenyx is a development-stage biopharmaceutical company committed to bringing to market novel products for the treatment of rare and ultra-rare diseases, with an initial focus on serious, debilitating genetic diseases. Founded in 2010, the company has rapidly built a diverse portfolio of product candidates with the potential to address diseases for which the unmet medical need is high, the biology for treatment is clear, and for which there are no approved therapies.

The company is led by a management team experienced in the development and commercialization of rare disease therapeutics. Ultragenyx's strategy is predicated upon time and cost-efficient drug development, with the goal of delivering safe and effective therapies to patients with the utmost urgency.

For more information on Ultragenyx, please visit the company's website at www.ultragenyx.com.

CONTACT: Contact Ultragenyx Pharmaceutical Inc.
         844-758-7273
         For Media, Bee NguyenFor Investors, Robert Anstey
Source: Ultragenyx Pharmaceutical Inc.

This article appears in: News Headlines

Referenced Stocks: RARE


Latest News Video





Most Active by Volume

Company Last Sale Change Net / %
HTZ $ 30.33 1.23 ▼ 3.90%
BAC $ 15.52 0.07 ▲ 0.45%
AAPL $ 100.57 0.04 ▲ 0.04%
NOK $ 8.13 0.11 ▲ 1.37%
FOLD $ 5.50 0.93 ▲ 20.35%
JCP $ 10.33 0.08 ▲ 0.78%
IRF $ 39.10 12.54 ▲ 47.21%
GE $ 26.36 0.31 ▲ 1.19%

As of 8/20/2014, 04:04 PM